Cancer Researcher Who Pioneered Melanoma Treatment Tries Immunotherapy-First for His Own Brain Cancer

Professor Richard Scolyer, the Australian pathologist who co-led the Melanoma Institute and was named Australian of the Year in 2024, died from glioblastoma at 59 in June 2026—nearly two years after diagnosis, double the median survival time. Before surgery, he became the first person globally to receive immunotherapy for brain cancer, applying principles from his own melanoma research to his own case.